| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |